시장보고서

상품코드

1674128

수막염균 백신 시장 : 유형별, 판매채널별, 연령층별, 지역별

Meningococcal Vaccines Market, By Type, By Sales Channel, By Age Group, By Geography

발행일: 2025년 02월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 수막염균 백신 시장은 2025년에 45억 3,000만 달러로 추정되며, 2032년에는 90억 5,000만 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 10.4%로 성장할 전망입니다.

보고서 범위		보고서 상세 내용
기준연도	2024년	2025년 시장 규모	45억 3,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 : 2025-2032년 CAGR	10.40%	2032년 금액 예측	90억 5,000만 달러

도표. 2025년 지역별 수막구균 백신 시장 점유율(%)

수막염균 감염은 수막염이나 패혈증을 유발하는 세균성 감염으로, 신속하게 치료하지 않으면 심각한 질병이나 사망에 달할 수 있습니다. 침습성 수막염균성 질환의 유병률 증가와 더불어, 이러한 감염성 질환에 대한 효과적인 백신이 있다는 인식이 높아짐에 따라 수막염균 백신에 대한 수요가 전 세계에서 증가할 수 있습니다. 또한 새로운 혈청형에 대한 새로운 결합형 백신의 연구개발이 진행 중이며, 전 세계에서 백신 접종 프로그램이 확대되고 있으며, 가까운 시일 내에 시장 관계자들에게 많은 기회를 제공할 수 있을 것으로 보입니다. 그러나 백신 개발과 관련된 높은 비용과 대체품의 위협과 같은 요인이 시장 성장을 저해할 수 있습니다.

시장 역학

세계 수막구균 백신 시장 성장의 원동력은 인구통계학적 및 생활양식 변화로 인한 침습성 수막구균 질환의 전 세계 유병률 증가입니다. 세계보건기구(WHO)에 따르면 매년 전 세계에서 약 120만 건의 수막구균성 수막염이 발생하여 약 13만 5,000명이 사망하고 있습니다. 국가 예방접종 스케줄을 통해 주요 혈청형에 대한 예방접종 프로그램을 추진하는 정부 및 보건기관의 구상이 증가함에 따라 수막구균 백신 접종률이 증가하고 있습니다. 새로운 혈청군에 대한 방어를 제공하는 차세대 다가수막구균 백신의 채택은 시장 진출기업에게 기회를 제공합니다. 그러나 새로운 수막구균 백신 개발과 관련된 높은 R&D 비용은 대체 치료 옵션의 가용성과 함께 시장 성장을 저해하는 요인으로 작용할 수 있습니다.

본 조사의 주요 특징

세계의 수막구균 백신 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR%)을 게재하고 있습니다.
또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
이 보고서는 세계의 수막구균 백신 시장의 주요 기업을 기업 개요, 제품 포트폴리오, 주요 특징, 주요 성과, 전략 등의 매개 변수를 기반으로 프로파일을 작성했습니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
세계의 수막구균 백신 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 수막구균 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

기업 개요
- GlaxoSmithKline plc
- Pfizer Inc.
- Sanofi Pasteur
- Merck & Co., Inc.
- Serum Institute of India Pvt. Ltd.
- Walvax BIoTechnology Co., Ltd.
- Hualan Biological Engineering Inc.
- JN-International Medical Corporation
- Beijing Minhai BIoTechnology Co., Ltd
- Bio-Manguinhos/Fiocruz
- Chongqing Zhifei Biological Products Co., Ltd.
- Baxter International
- CSL Limited
- Bavarian Nordic
- Incepta Vaccine Ltd.
- Sinovac BIoTech Ltd.
- Novartis
- Panacea BIoTec Ltd

제10장 애널리스트의 권장사항

운명의 수레바퀴
COM(Coherent Opportunity Map)

제11장 참고 문헌과 조사 방법

참고 문헌
조사 방법

KSA 25.04.03

Global Meningococcal Vaccines Market is estimated to be valued at USD 4.53 Bn in 2025 and is expected to reach USD 9.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 4.53 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.40%	2032 Value Projection:	USD 9.05 Bn

Figure. Meningococcal Vaccines Market Share (%), By Region 2025

Meningococcal disease refers to the bacterial infections causing meningitis and sepsis that can lead to serious illness or even death, if not promptly treated. Rising prevalence of these invasive meningococcal diseases along with growing awareness about the availability of effective vaccines against such infections can boost demand for meningococcal vaccines globally. Furthermore, ongoing research & development activities for new conjugate vaccines against additional serotypes and expanding vaccination programs worldwide can offer numerous opportunities for market players in the near future. However, factors such as high costs associated with vaccine development and threats of substitutes can hamper the market growth.

Market Dynamics:

Global meningococcal vaccines market growth is driven by rising prevalence of invasive meningococcal diseases worldwide due to changing demographics and lifestyle patterns. According to the World Health Organization (WHO), approximately 1.2 million cases of meningococcal meningitis occur every year across the globe, leading to around 135,000 deaths. Growing initiatives by governments and health agencies to promote immunization programs against major serotypes through national vaccination schedules boosts uptake of meningococcal vaccines. Introduction of newer generation multivalent meningococcal vaccines providing protection against additional serogroups can offer opportunities for market players. However, high research and development costs associated with development of novel meningococcal vaccines along with availability of alternative treatment options can hamper the market growth.

Key Features of the Study:

This report provides in-depth analysis of the global meningococcal vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global meningococcal vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi SA, Pfizer Inc., Merck & Co., Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global meningococcal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningococcal vaccines market

Detailed Segmentation-

By Type
- Polysaccharide Vaccines
- Conjugate Vaccines
- Combination Vaccines
- Other
By Sales Channel
- Public
- Private
By Age Group
- Infants (0 to 2 years)
- Children and Adults (2 years & above)
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- GlaxoSmithKline plc
- Pfizer Inc.
- Sanofi Pasteur
- Merck & Co., Inc.
- Serum Institute of India Pvt. Ltd.
- Walvax Biotechnology Co., Ltd.
- Hualan Biological Engineering Inc.
- JN-International Medical Corporation
- Beijing Minhai Biotechnology Co., Ltd
- Bio-Manguinhos/Fiocruz
- Chongqing Zhifei Biological Products Co., Ltd.
- Baxter International
- CSL Limited
- Bavarian Nordic
- Incepta Vaccine Ltd.
- Sinovac Biotech Ltd.
- Novartis
- Panacea Biotec Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Sales Channel
- Market Snapshot, By Age Group
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Meningococcal Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Meningococcal Vaccines Market, By Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Polysaccharide Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Conjugate Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Combination Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Meningococcal Vaccines Market, By Sales Channel, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Meningococcal Vaccines Market, By Age Group, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Infants (0 to 2 years)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Children and Adults (2 years & above)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Meningococcal Vaccines Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline plc
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi Pasteur
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Walvax Biotechnology Co., Ltd.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Hualan Biological Engineering Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- JN-International Medical Corporation
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Beijing Minhai Biotechnology Co., Ltd
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio-Manguinhos/Fiocruz
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Chongqing Zhifei Biological Products Co., Ltd.
- Baxter International
- CSL Limited
- Bavarian Nordic
- Incepta Vaccine Ltd.
- Sinovac Biotech Ltd.
- Novartis
- Panacea Biotec Ltd

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

수막염균 백신 시장 : 유형별, 판매채널별, 연령층별, 지역별

Meningococcal Vaccines Market, By Type, By Sales Channel, By Age Group, By Geography

시장 역학

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 세계의 수막염균 백신 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

제5장 세계의 수막염균 백신 시장, 유형별, 2020-2032년(10억 달러)

제6장 세계의 수막염균 백신 시장, 판매채널별, 2020-2032년(10억 달러)

제7장 세계의 수막염균 백신 시장, 연령층별, 2020-2032년(10억 달러)

제8장 세계의 수막염균 백신 시장, 지역별, 2020-2032년(10억 달러)

제9장 경쟁 구도